Prodotti GS / Area HIV
Area HIV_Variazioni RCP_Agosto 2021
![Immagine News](/media/0icnkhat/cat-1.jpg?center=0.55476190476190479,0.25&mode=crop&width=722&height=442)
Product |
Submission description |
RCP availability |
Atripla | ||
Emtriva |
|
|
Viread |
HBV-GS-US-0174-0144-(wk 192)-Article-46 |
Inizio Dicembre 2021 |
Stribild |
Type II variation to submit DDI with cutaneous corticosteroids
|
Ottobre 2021 |
Truvada |
Type II variation to remove the additional risk minimisation measures for the PrEP indication risks, from the Truvada EU-RMP and update the RMP to version 17.2 |
Inizio Novembre 2021 |
Eviplera |
|
|
Genvoya | Type II variation to submit DDI with cutaneous corticosteroids | Ottobre 2021 |
Descovy |
|
|
Odefsey |
|
|
Biktarvy |
|
|
Newsletter Agosto 2021 |
Grazie per il tuo feedback!